Total Payments
$6,409
2024 Payments
$527.40
Companies
21
Transactions
465
Medicare Patients
3,597
Medicare Billing
$575,257
Payment Breakdown by Category
Food & Beverage$6,277 (97.9%)
Education$132.32 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,277 | 461 | 97.9% |
| Education | $132.32 | 4 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $1,118 | 76 | $0 (2022) |
| Allergan, Inc. | $1,005 | 122 | $0 (2020) |
| ABBVIE INC. | $819.17 | 58 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $713.66 | 44 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $653.82 | 47 | $0 (2024) |
| ITI, Inc. | $581.56 | 27 | $0 (2023) |
| Lundbeck LLC | $480.78 | 31 | $0 (2024) |
| Alkermes, Inc. | $302.36 | 20 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $145.86 | 8 | $0 (2024) |
| Indivior Inc. | $119.28 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $527.40 | 29 | ABBVIE INC. ($94.20) |
| 2023 | $436.19 | 29 | ABBVIE INC. ($171.28) |
| 2022 | $1,284 | 75 | ABBVIE INC. ($357.49) |
| 2021 | $1,073 | 70 | ITI, Inc. ($276.53) |
| 2020 | $1,188 | 94 | Allergan, Inc. ($436.39) |
| 2019 | $1,028 | 95 | Allergan Inc. ($376.06) |
| 2018 | $481.76 | 46 | Sunovion Pharmaceuticals Inc. ($164.37) |
| 2017 | $391.50 | 27 | Sunovion Pharmaceuticals Inc. ($102.88) |
All Payment Transactions
465 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: OUD | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $15.33 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Central Nervous System | ||||||
| 11/06/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Neuroscience | ||||||
| 10/28/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: OUD | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Neurology | ||||||
| 08/21/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: OUD | ||||||
| 08/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Central Nervous System | ||||||
| 08/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.94 | General |
| Category: PSYCHIATRY | ||||||
| 07/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: OUD | ||||||
| 06/24/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: BH | ||||||
| 06/06/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Neuroscience | ||||||
| 06/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Neuropsychiatry | ||||||
| 04/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.00 | General |
| Category: PSYCHIATRY | ||||||
| 04/11/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/10/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Neuroscience | ||||||
| 03/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 784 | 1,917 | $394,815 | $133,426 |
| 2022 | 10 | 783 | 2,027 | $389,788 | $134,569 |
| 2021 | 11 | 759 | 2,034 | $376,751 | $130,277 |
| 2020 | 15 | 1,271 | 15,582 | $549,610 | $176,985 |
Total Patients
3,597
Total Services
21,560
Medicare Billing
$575,257
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 161 | 445 | $83,500 | $32,248 | 38.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 114 | 360 | $79,200 | $21,916 | 27.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 217 | $49,710 | $19,226 | 38.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 104 | 245 | $53,900 | $17,702 | 32.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 207 | $31,398 | $12,107 | 38.6% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 124 | 195 | $27,768 | $8,131 | 29.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 51 | 51 | $21,960 | $6,688 | 30.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 30 | $12,804 | $3,807 | 29.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 33 | 40 | $8,979 | $3,399 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 44 | 58 | $8,700 | $2,686 | 30.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 18 | 18 | $6,360 | $2,219 | 34.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 21 | $6,036 | $1,861 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 30 | $4,500 | $1,434 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 153 | 626 | $134,546 | $44,210 | 32.9% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 170 | 510 | $91,800 | $30,628 | 33.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 45 | 202 | $42,420 | $15,373 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 92 | 202 | $29,130 | $8,994 | 30.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 31 | 130 | $18,980 | $6,872 | 36.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 55 | 55 | $14,688 | $6,767 | 46.1% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 99 | 142 | $19,454 | $6,376 | 32.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 29 | 29 | $7,824 | $4,266 | 54.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 41 | 50 | $10,650 | $3,857 | 36.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 24 | $9,768 | $3,539 | 36.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 21 | $4,512 | $1,418 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 22 | $3,174 | $1,296 | 40.8% |
About Dr. Rogerio Ramos, M.D
Dr. Rogerio Ramos, M.D is a Psychiatry healthcare provider based in Mason City, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1295927291.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rogerio Ramos, M.D has received a total of $6,409 in payments from pharmaceutical and medical device companies, with $527.40 received in 2024. These payments were reported across 465 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($6,277).
As a Medicare-enrolled provider, Ramos has provided services to 3,597 Medicare beneficiaries, totaling 21,560 services with total Medicare billing of $575,257. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Mason City, IA
- Active Since 08/14/2007
- Last Updated 02/13/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295927291
Products in Payments
- VRAYLAR (Drug) $1,824
- LATUDA (Drug) $1,118
- REXULTI (Drug) $974.16
- CAPLYTA (Drug) $615.17
- SPRAVATO (Drug) $444.12
- ARISTADA (Drug) $254.46
- INVEGA SUSTENNA (Drug) $209.70
- ABILIFY MAINTENA (Drug) $152.30
- INGREZZA (Drug) $97.41
- VIBATIV (Drug) $71.10
- Auvelity (Drug) $70.87
- SUBLOCADE (Drug) $67.31
- Trintellix (Drug) $63.60
- Austedo XR (Drug) $58.60
- BRINTELLIX (Drug) $57.55
- AUSTEDO (Drug) $52.49
- PERSERIS (Drug) $51.97
- Aristada 441 mg (Drug) $39.39
- FANAPT (Drug) $38.72
- JORNAY PM (Drug) $37.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.